Spectrum: Local Antimicrobial Stewardship, for Prisma Health-Midlands

Fidaxomicin

Restricted
Restricted

C. diff Risk

None

Oral Bioavailability

None

Approximate Cost

Spectrum Of Activity

General Spectrum of Activity

Spectrum Of Activity

Dosing

Adult

C. difficile 200mg po BID x 10days

General Information

Common Usage

Common Usage

C. difficile colitis

Adverse Effects

Adverse Effects

  • GI disturbance

  • Cytopenias

  • Hypersensitivity: facial, tongue or throat swelling

Additional Information

Additional Information

Consult Infectious Disease

Pharmacology

Pharmacology

Antimicrobial class: Specialized anti-C. difficile macrocyclic agent

Pregnancy category: B

Urine penetration: None

Lung penetration: None

CSF penetration: None

Biliary penetration: None